back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2026-09-04 12:15 Tx date 2026-09-01 |
$XENE
Xenon Pharmaceuticals Inc. |
Svoronos, Dawn
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$41,923
+5,144 vol $8.15 each |
31,373 | |
| Filed 2026-09-04 12:13 Tx date 2026-09-01 |
$XENE
Xenon Pharmaceuticals Inc. |
Svoronos, Dawn
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
-5,144 vol |
133,036 | |
| Filed 2026-09-01 18:38 Tx date 2026-08-28 |
$XENE
Xenon Pharmaceuticals Inc. |
Kenney, Christopher John
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-42,683.62
-700 vol $60.98 each |
1 | |
| Filed 2026-09-01 18:37 Tx date 2026-08-28 |
$XENE
Xenon Pharmaceuticals Inc. |
Kenney, Christopher John
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-383,145.3664
-6,368 vol $60.17 each |
701 | |
| Filed 2026-08-14 21:39 Tx date 2026-08-11 |
$XENE
Xenon Pharmaceuticals Inc. |
Gannon, Steven
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-512,440
-8,000 vol $64.06 each |
1,870 | |
| Filed 2026-08-14 21:23 Tx date 2026-08-11 |
$XENE
Xenon Pharmaceuticals Inc. |
Gannon, Steven
4 - Director of Issuer
Holder: 9465-2138 Québec inc. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
-2,000 vol |
0 | |
| Filed 2026-08-14 20:46 Tx date 2026-05-12 |
$XENE
Xenon Pharmaceuticals Inc. |
Gannon, Steven
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$25,830
+3,500 vol $7.38 each |
8,641 | |
| Filed 2026-08-14 20:37 Tx date 2026-05-12 |
$XENE
Xenon Pharmaceuticals Inc. |
Gannon, Steven
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
-3,500 vol |
122,529 | |
| Filed 2026-06-09 18:37 Tx date 2026-06-05 |
$XENE
Xenon Pharmaceuticals Inc. |
Cannon, Gillian
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-63,236.60
-1,190 vol $53.14 each |
1,455 | |
| Filed 2026-06-09 18:35 Tx date 2026-06-05 |
$XENE
Xenon Pharmaceuticals Inc. |
Patou, Gary
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-70,251.08
-1,322 vol $53.14 each |
29,787 | |
| Filed 2026-06-05 17:33 Tx date 2026-06-03 |
$XENE
Xenon Pharmaceuticals Inc. |
Patou, Gary
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+1,593 vol |
1,593 | |
| Filed 2026-06-05 17:33 Tx date 2026-06-03 |
$XENE
Xenon Pharmaceuticals Inc. |
Patou, Gary
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+10,507 vol |
133,036 | |
| Filed 2026-06-05 17:30 Tx date 2026-06-01 |
$XENE
Xenon Pharmaceuticals Inc. |
Patou, Gary
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+2,645 vol |
31,109 | |
| Filed 2026-06-05 17:25 Tx date 2026-06-01 |
$XENE
Xenon Pharmaceuticals Inc. |
Patou, Gary
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-2,645 vol |
0 | |
| Filed 2026-06-05 17:22 Tx date 2026-06-03 |
$XENE
Xenon Pharmaceuticals Inc. |
Machado, Patrick
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+1,593 vol |
1,593 | |
| Filed 2026-06-05 17:21 Tx date 2026-06-03 |
$XENE
Xenon Pharmaceuticals Inc. |
Machado, Patrick
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+10,507 vol |
109,536 | |
| Filed 2026-06-05 17:18 Tx date 2026-06-01 |
$XENE
Xenon Pharmaceuticals Inc. |
Machado, Patrick
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+2,645 vol |
2,645 | |
| Filed 2026-06-05 17:18 Tx date 2020-11-05 |
$XENE
Xenon Pharmaceuticals Inc. |
Machado, Patrick
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2026-06-05 17:17 Tx date 2026-06-01 |
$XENE
Xenon Pharmaceuticals Inc. |
Machado, Patrick
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-2,645 vol |
0 | |
| Filed 2026-06-05 15:52 Tx date 2026-06-03 |
$XENE
Xenon Pharmaceuticals Inc. |
Gover, Justin
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+1,593 vol |
1,593 |